跳转至内容
Merck
CN

330729P

Avanti

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0)

Avanti Research™ - A Croda Brand

别名:

D-glucosyl-β-1,1′-N-pentadecanoyl-D-erythro-sphingosine-d7

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C39H68D7NO8
化学文摘社编号:
2315262-18-9
分子量:
693.06
MDL number:
MFCD35064278
UNSPSC Code:
12352211
NACRES:
NA.12
Assay:
99% (TLC)
Form:
powder

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

[H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

assay

99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (330729P-1MG)

manufacturer/tradename

Avanti Research™ - A Croda Brand

shipped in

dry ice

storage temp.

−20°C

General description

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) is a deuterated derivative of C15 Glucosyl(β) Ceramide. β-Glucosyl ceramide (β-GlcCer) is an intracellular metabolite. It is the first intermediate in the synthesis of glycosphigolipids. β-GlcCer is an endogenous ligand of Mincle.

Biochem/physiol Actions

β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.

Packaging

5 mL Amber Glass Screw Cap Vial

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Intracellular metabolite beta-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
Nagata M, et al.
Proceedings of the National Academy of Sciences of the USA, 114(16), E3285-E3294 (2017)

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持